We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Case Study · August 02, 2017

Hair Repigmentation During Anti–PD-1 and Anti–PD-L1 Immunotherapy for Lung Cancer

JAMA Dermatology


Additional Info

JAMA Dermatology
Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer
JAMA Dermatol 2017 Jul 12;[EPub Ahead of Print], N Rivera, A Boada, MI Bielsa, MT Fernández-Figueras, E Carcereny, MT Moran, C Ferrándiz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading